These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Infrequent SCN9A mutations in congenital insensitivity to pain and erythromelalgia. Klein CJ; Wu Y; Kilfoyle DH; Sandroni P; Davis MD; Gavrilova RH; Low PA; Dyck PJ J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):386-91. PubMed ID: 23129781 [TBL] [Abstract][Full Text] [Related]
15. Anomalous enhancement of resurgent Na Huang CW; Lai HJ; Huang PY; Lee MJ; Kuo CC Sci Rep; 2019 Aug; 9(1):12251. PubMed ID: 31439884 [TBL] [Abstract][Full Text] [Related]
16. Sodium channel slow inactivation interferes with open channel block. Hampl M; Eberhardt E; O'Reilly AO; Lampert A Sci Rep; 2016 May; 6():25974. PubMed ID: 27174182 [TBL] [Abstract][Full Text] [Related]
17. A Novel SCN9A Mutation (F826Y) in Primary Erythromelalgia Alters the Excitability of Nav1.7. Wu B; Zhang Y; Tang H; Yang M; Long H; Shi G; Tang J; Shi X Curr Mol Med; 2017; 17(6):450-457. PubMed ID: 28990532 [TBL] [Abstract][Full Text] [Related]
18. Erythromelalgia caused by the missense mutation p.Arg220Pro in an alternatively spliced exon of SCN9A (NaV1.7). Deuis JR; Kumble S; Keramidas A; Ragnarsson L; Simons C; Pais L; White SM; Vetter I Hum Mol Genet; 2024 Jan; 33(2):103-109. PubMed ID: 37721535 [TBL] [Abstract][Full Text] [Related]
19. A severe case of primary erythromelalgia presenting as small fiber neuropathy with a novel SCN9A mutation. Watabe D; Tominaga M; Toyama S; Takamori K; Nakano H; Amano H J Dermatol; 2023 Jul; 50(7):938-941. PubMed ID: 36815391 [TBL] [Abstract][Full Text] [Related]
20. What are the treatment options for paroxysmal extreme pain disorder? Suter MR Pain Manag; 2015; 5(4):229-32. PubMed ID: 26059255 [No Abstract] [Full Text] [Related] [Next] [New Search]